SIRT1 and metabolic syndrome: Decreased levels of Sirtuin 1 have been shown to be associated with the diagnosis of diabetes mellitus, nonalcoholic fatty liver disease, and the metabolic syndrome, in which epigenetic modifications may play an important role (49, 51–53).